135 related articles for article (PubMed ID: 38579649)
41. Burden of non-communicable diseases from infectious causes in 2017: a modelling study.
Coates MM; Kintu A; Gupta N; Wroe EB; Adler AJ; Kwan GF; Park PH; Rajbhandari R; Byrne AL; Casey DC; Bukhman G
Lancet Glob Health; 2020 Dec; 8(12):e1489-e1498. PubMed ID: 33098769
[TBL] [Abstract][Full Text] [Related]
42. Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
Blakely T; Kvizhinadze G; Atkinson J; Dieleman J; Clarke P
PLoS Med; 2019 Jan; 16(1):e1002716. PubMed ID: 30620729
[TBL] [Abstract][Full Text] [Related]
43. Economic burden of low cardiorespiratory fitness in Canada.
Chaput JP; Janssen I; Sampasa-Kanyinga H; Tomkinson GR; Lang JJ
Prev Med; 2023 Mar; 168():107424. PubMed ID: 36682702
[TBL] [Abstract][Full Text] [Related]
44. Health burden and costs of obesity and overweight in Germany: an update.
Lehnert T; Streltchenia P; Konnopka A; Riedel-Heller SG; König HH
Eur J Health Econ; 2015 Dec; 16(9):957-67. PubMed ID: 25381038
[TBL] [Abstract][Full Text] [Related]
45. Economic burden of obesity and its comorbidities in Switzerland.
Schmid A; Schneider H; Golay A; Keller U
Soz Praventivmed; 2005; 50(2):87-94. PubMed ID: 15900961
[TBL] [Abstract][Full Text] [Related]
46. Direct healthcare cost of obesity in brazil: an application of the cost-of-illness method from the perspective of the public health system in 2011.
de Oliveira ML; Santos LM; da Silva EN
PLoS One; 2015; 10(4):e0121160. PubMed ID: 25830909
[TBL] [Abstract][Full Text] [Related]
47. The economic burden of self-reported and undiagnosed cardiovascular diseases and diabetes on Indonesian households.
Finkelstein EA; Chay J; Bajpai S
PLoS One; 2014; 9(6):e99572. PubMed ID: 24915510
[TBL] [Abstract][Full Text] [Related]
48. Direct and Indirect Costs of Diabetes in Brazil in 2016.
Pereda P; Boarati V; Guidetti B; Duran AC
Ann Glob Health; 2022; 88(1):14. PubMed ID: 35340368
[TBL] [Abstract][Full Text] [Related]
49. The economic impact of cancer mortality among working-age individuals in Brazil from 2001 to 2030.
De Camargo Cancela M; Monteiro Dos Santos JE; Lopes de Souza LB; Martins LFL; Bezerra de Souza DL; Barchuk A; Hanly P; Sharp L; Soerjomataram I; Pearce A
Cancer Epidemiol; 2023 Oct; 86():102438. PubMed ID: 37579673
[TBL] [Abstract][Full Text] [Related]
50. Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System.
Goncalves GMR; Silva END
PLoS One; 2018; 13(10):e0203992. PubMed ID: 30273345
[TBL] [Abstract][Full Text] [Related]
51. Application of the UK foresight obesity model in Ireland: the health and economic consequences of projected obesity trends in Ireland.
Keaver L; Webber L; Dee A; Shiely F; Marsh T; Balanda K; Perry IJ
PLoS One; 2013; 8(11):e79827. PubMed ID: 24236162
[TBL] [Abstract][Full Text] [Related]
52. Economic burden of sickle cell disease in Brazil.
Silva-Pinto AC; Costa FF; Gualandro SFM; Fonseca PBB; Grindler CM; Souza Filho HCR; Bueno CT; Cançado RD
PLoS One; 2022; 17(6):e0269703. PubMed ID: 35709301
[TBL] [Abstract][Full Text] [Related]
53. Delivering a primary-level non-communicable disease programme for Syrian refugees and the host population in Jordan: a descriptive costing study.
Ansbro É; Garry S; Karir V; Reddy A; Jobanputra K; Fardous T; Sadique Z
Health Policy Plan; 2020 Oct; 35(8):931-940. PubMed ID: 32621490
[TBL] [Abstract][Full Text] [Related]
54. The national economic burden of rare disease in the United States in 2019.
Yang G; Cintina I; Pariser A; Oehrlein E; Sullivan J; Kennedy A
Orphanet J Rare Dis; 2022 Apr; 17(1):163. PubMed ID: 35414039
[TBL] [Abstract][Full Text] [Related]
55. Mortality, hospital days and treatment costs of current and reduced sugar consumption in Israel.
Ginsberg GM
Isr J Health Policy Res; 2017; 6():1. PubMed ID: 28096974
[TBL] [Abstract][Full Text] [Related]
56. What affects the direct economic burden of non-communicable diseases on middle-aged and older adult people in Shaanxi Province?
Yang X; Yan J; Lai S; Shen C; Duan N
Front Public Health; 2023; 11():1219199. PubMed ID: 38186709
[TBL] [Abstract][Full Text] [Related]
57. Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review.
Bertoldi AD; Kanavos P; França GV; Carraro A; Tejada CA; Hallal PC; Ferrario A; Schmidt MI
Global Health; 2013 Dec; 9():62. PubMed ID: 24299125
[TBL] [Abstract][Full Text] [Related]
58. Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic.
Wang Y; Beydoun MA; Liang L; Caballero B; Kumanyika SK
Obesity (Silver Spring); 2008 Oct; 16(10):2323-30. PubMed ID: 18719634
[TBL] [Abstract][Full Text] [Related]
59. Economic Costs Attributable to Smoking in Hong Kong in 2011: A Possible Increase From 1998.
Chen J; McGhee S; Lam TH
Nicotine Tob Res; 2019 Mar; 21(4):505-512. PubMed ID: 29149286
[TBL] [Abstract][Full Text] [Related]
60. Economic burden of low physical activity and high sedentary behaviour in Finland.
Kolu P; Kari JT; Raitanen J; Sievänen H; Tokola K; Havas E; Pehkonen J; Tammelin TH; Pahkala K; Hutri-Kähönen N; Raitakari OT; Vasankari T
J Epidemiol Community Health; 2022 Jul; 76(7):677-684. PubMed ID: 35473717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
